192 related articles for article (PubMed ID: 35903095)
1. Single-Cell Transcriptomic Analysis Reveals the Crosstalk Propensity Between the Tumor Intermediate State and the CD8+ T Exhausted State to be Associated with Clinical Benefits in Melanoma.
Zhu J; Yan M; Yan H; Xu L; Jiang Z; Liao G; Zhou Y; Liu W; Liang X; Li X; Xiao Y; Zhang Y
Front Immunol; 2022; 13():766852. PubMed ID: 35903095
[TBL] [Abstract][Full Text] [Related]
2. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
3. Single-Cell Transcriptomic Analysis Reveals a Tumor-Reactive T Cell Signature Associated With Clinical Outcome and Immunotherapy Response In Melanoma.
Yan M; Hu J; Ping Y; Xu L; Liao G; Jiang Z; Pang B; Sun S; Zhang Y; Xiao Y; Li X
Front Immunol; 2021; 12():758288. PubMed ID: 34804045
[TBL] [Abstract][Full Text] [Related]
4. Deciphering the transcriptomic landscape of tumor-infiltrating CD8 lymphocytes in B16 melanoma tumors with single-cell RNA-Seq.
Carmona SJ; Siddiqui I; Bilous M; Held W; Gfeller D
Oncoimmunology; 2020; 9(1):1737369. PubMed ID: 32313720
[TBL] [Abstract][Full Text] [Related]
5. Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma.
Sade-Feldman M; Yizhak K; Bjorgaard SL; Ray JP; de Boer CG; Jenkins RW; Lieb DJ; Chen JH; Frederick DT; Barzily-Rokni M; Freeman SS; Reuben A; Hoover PJ; Villani AC; Ivanova E; Portell A; Lizotte PH; Aref AR; Eliane JP; Hammond MR; Vitzthum H; Blackmon SM; Li B; Gopalakrishnan V; Reddy SM; Cooper ZA; Paweletz CP; Barbie DA; Stemmer-Rachamimov A; Flaherty KT; Wargo JA; Boland GM; Sullivan RJ; Getz G; Hacohen N
Cell; 2018 Nov; 175(4):998-1013.e20. PubMed ID: 30388456
[TBL] [Abstract][Full Text] [Related]
6. Induction of Progenitor Exhausted Tissue-Resident Memory CD8
León-Letelier RA; Castro-Medina DI; Badillo-Godinez O; Tepale-Segura A; Huanosta-Murillo E; Aguilar-Flores C; De León-Rodríguez SG; Mantilla A; Fuentes-Pananá EM; López-Macías C; Bonifaz LC
Front Immunol; 2020; 11():583382. PubMed ID: 33240271
[TBL] [Abstract][Full Text] [Related]
7. 9-Gene Signature Correlated With CD8
Yan K; Lu Y; Yan Z; Wang Y
Front Immunol; 2021; 12():622563. PubMed ID: 34220795
[TBL] [Abstract][Full Text] [Related]
8. Dissecting cellular states of infiltrating microenvironment cells in melanoma by integrating single-cell and bulk transcriptome analysis.
Shi A; Yan M; Pang B; Pang L; Wang Y; Lan Y; Zhang X; Xu J; Ping Y; Hu J
BMC Immunol; 2023 Dec; 24(1):52. PubMed ID: 38082384
[TBL] [Abstract][Full Text] [Related]
9. Activation of NKT Cells in an Anti-PD-1-Resistant Tumor Model Enhances Antitumor Immunity by Reinvigorating Exhausted CD8 T Cells.
Bae EA; Seo H; Kim BS; Choi J; Jeon I; Shin KS; Koh CH; Song B; Kim IK; Min BS; Han YD; Shin SJ; Kang CY
Cancer Res; 2018 Sep; 78(18):5315-5326. PubMed ID: 30012672
[TBL] [Abstract][Full Text] [Related]
10. Correlation of tumor-infiltrating immune cells of melanoma with overall survival by immunogenomic analysis.
Huang L; Chen H; Xu Y; Chen J; Liu Z; Xu Q
Cancer Med; 2020 Nov; 9(22):8444-8456. PubMed ID: 32931642
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the treatment-naive immune microenvironment in melanoma with
Wang M; Zadeh S; Pizzolla A; Thia K; Gyorki DE; McArthur GA; Scolyer RA; Long G; Wilmott JS; Andrews MC; Au-Yeung G; Weppler A; Sandhu S; Trapani JA; Davis MJ; Neeson PJ
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35383113
[TBL] [Abstract][Full Text] [Related]
12. Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Li H; van der Leun AM; Yofe I; Lubling Y; Gelbard-Solodkin D; van Akkooi ACJ; van den Braber M; Rozeman EA; Haanen JBAG; Blank CU; Horlings HM; David E; Baran Y; Bercovich A; Lifshitz A; Schumacher TN; Tanay A; Amit I
Cell; 2019 Feb; 176(4):775-789.e18. PubMed ID: 30595452
[TBL] [Abstract][Full Text] [Related]
13. The potential crosstalk between tumor and plasma cells and its association with clinical outcome and immunotherapy response in bladder cancer.
Long F; Wang W; Li S; Wang B; Hu X; Wang J; Xu Y; Liu M; Zhou J; Si H; Xi X; Meng XY; Yuan C; Wang F
J Transl Med; 2023 May; 21(1):298. PubMed ID: 37138324
[TBL] [Abstract][Full Text] [Related]
14. Tissue-resident memory T cells from a metastatic vaginal melanoma patient are tumor-responsive T cells and increase after anti-PD-1 treatment.
Pizzolla A; Keam SP; Vergara IA; Caramia F; Thio N; Wang M; Kocovski N; Tantalo D; Jabbari J; Au-Yeung G; Sandhu S; Gyorki DE; Weppler A; Perdicchio M; McArthur GA; Papenfuss AT; Neeson PJ
J Immunother Cancer; 2022 May; 10(5):. PubMed ID: 35550554
[TBL] [Abstract][Full Text] [Related]
15. Single-cell RNA-sequencing analyses identify heterogeneity of CD8
Deng W; Ma Y; Su Z; Liu Y; Liang P; Huang C; Liu X; Shao J; Zhang Y; Zhang K; Chen J; Li R
Mol Ther Oncolytics; 2021 Mar; 20():105-118. PubMed ID: 33575475
[TBL] [Abstract][Full Text] [Related]
16. Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer.
Du Y; Lin Y; Gan L; Wang S; Chen S; Li C; Hou S; Hu B; Wang B; Ye Y; Shen Z
J Transl Med; 2024 Feb; 22(1):158. PubMed ID: 38365757
[TBL] [Abstract][Full Text] [Related]
17. B Cells Are Required to Generate Optimal Anti-Melanoma Immunity in Response to Checkpoint Blockade.
Singh S; Roszik J; Saini N; Singh VK; Bavisi K; Wang Z; Vien LT; Yang Z; Kundu S; Davis RE; Bover L; Diab A; Neelapu SS; Overwijk WW; Rai K; Singh M
Front Immunol; 2022; 13():794684. PubMed ID: 35720386
[TBL] [Abstract][Full Text] [Related]
18. Development and Validation of a CD8+ T Cell Infiltration-Related Signature for Melanoma Patients.
Yuan Y; Zhu Z; Lan Y; Duan S; Zhu Z; Zhang X; Li G; Qu H; Feng Y; Cai H; Song Z
Front Immunol; 2021; 12():659444. PubMed ID: 34040608
[TBL] [Abstract][Full Text] [Related]
19. Single-cell sequencing reveals antitumor characteristics of intratumoral immune cells in old mice.
Zhang C; Lei L; Yang X; Ma K; Zheng H; Su Y; Jiao A; Wang X; Liu H; Zou Y; Shi L; Zhou X; Sun C; Hou Y; Xiao Z; Zhang L; Zhang B
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34642245
[TBL] [Abstract][Full Text] [Related]
20. CXCR6 is required for antitumor efficacy of intratumoral CD8
Wang B; Wang Y; Sun X; Deng G; Huang W; Wu X; Gu Y; Tian Z; Fan Z; Xu Q; Chen H; Sun Y
J Immunother Cancer; 2021 Aug; 9(8):. PubMed ID: 34462326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
